Upgrading the Treatment Algorithm for Advanced Ovarian Cancer

Advanced Ovarian Cancer Treatment StrategiesПодробнее

ASCO Resource-Stratified Guidelines for the Treatment of Epithelial Ovarian CancerПодробнее

AROC 2017: Update on Ovarian CancerПодробнее

Newly Diagnosed Advanced Ovarian Cancer: Treatment OverviewПодробнее

Personalizing Advanced Ovarian Cancer Treatment With PARP Inhibitors and Novel ApproachesПодробнее

Maintenance Therapy for Advanced Ovarian CancerПодробнее

Treatment Sequencing in Advanced Ovarian CancerПодробнее

3/26/2021: Upfront Treatment of Advanced Ovarian Cancer; Ay, Now the Plot ThickensПодробнее

The Advanced Ovarian Cancer Treatment Palette: Candid Conversations on PARP InhibitorsПодробнее

Improving the Management of Advanced Ovarian CancerПодробнее

Dr. Berger on Frontline Treatment Options in Newly Diagnosed Advanced Ovarian CancerПодробнее

Dr. Nguyen on Treatment Approaches for Patients With Advanced Ovarian CancerПодробнее

SOLO1: Maintenance olaparib in advanced BRCA ovarian cancerПодробнее

Is It Time to Change Upfront Chemotherapy for Ovarian Cancer?Подробнее

Advances in the Management of Advanced and Relapsed Ovarian CancerПодробнее

Rebastinib and paclitaxel for advanced/metastatic ovarian cancerПодробнее

Managing Recurrent Advanced Ovarian Cancer in the Current EraПодробнее

Updated recommendations for the management of advanced ovarian cancerПодробнее

Surgical Management of Advanced Ovarian CancerПодробнее

Managing Toxicities in Advanced Ovarian CancerПодробнее